Summary
Volledige samenvatting Epidemiologie & Economie van de Diergezondheidszorg
- Course
- Institution
In deze samenvatting vind je alle info voor beide onderdelen van het vak. Met duidelijke voorbeelden en uitwerkingen.
[Show more]
2 reviews
By: matisseruige • 1 year ago
By: louisawallays • 1 year ago
Seller
Follow
stuviatralala
Reviews received
Content preview
EPIDEMIOLOGIE& ECONOMIE VAN DE
DIERGEZONDHEIDS-
ZORG
2021 – 2022
1e bachelor Diergeneeskunde
,Inhoud
HOOFDSTUK 1: BASIS EPIDEMIOLOGISCHE CONCEPTEN .................................................................... 4
1.1 OORZAKEN VAN ZIEKTE IN EEN HISTORISCH PERSPECTIEF ................................................................... 4
1.2 HET MULTIFACTORIËLE KARAKTER VAN DE ZIEKTE ............................................................................ 4
1.3 HET VERBAND TUSSEN ZIEKTE EN RISICOFACTOREN .......................................................................... 5
1.4 ENKELE HISTORISCHE VOORBEELDEN ............................................................................................ 5
HOOFDSTUK 2: VOORKOMEN VAN ZIEKTE .................................................................................... 6
2.1 HET TELLEN VAN GEBEURTENISSEN .............................................................................................. 6
2.2 ENDEMISCHE EN EPIDEMISCHE ZIEKTEN......................................................................................... 6
2.3 (HER)OPKOMENDE ZIEKTEN ....................................................................................................... 7
2.4 METEN VAN ZIEKTEFREQUENTIE .................................................................................................. 7
HOOFDSTUK 3: ZIEKTETRANSMISSIE ......................................................................................... 10
3.1 INLEIDING ........................................................................................................................... 10
3.2 BRONNEN VAN INFECTIE ......................................................................................................... 10
3.3 ROUTES VAN ZIEKTETRANSMISSIE .............................................................................................. 11
3.4 KWANTIFICEREN VAN ZIEKTETRANSMISSIE ................................................................................... 11
HOOFDSTUK 4: MONITORING EN SURVEILLANCE .......................................................................... 13
4.1 GEVALSTUDIE OF GEVALREEKS .................................................................................................. 13
4.2 SURVEY .............................................................................................................................. 13
4.3 MONITORING ...................................................................................................................... 13
4.4 SURVEILLANCE ..................................................................................................................... 13
HOOFDSTUK 5: DIAGNOSTIEK ................................................................................................. 15
5.1 TESTKARAKTERISTIEKEN .......................................................................................................... 15
5.1.1 SENSITIVITEIT.......................................................................................................................................... 15
5.1.2 SPECIFICITEIT .......................................................................................................................................... 15
5.2 RELATIE TUSSEN SENSITIVITEIT EN SPECIFICITEIT ............................................................................ 16
5.4 RELATIE TUSSEN SENSITIVITEIT, SPECIFICITEIT EN PREVALENTIE .......................................................... 16
5.5 VOORSPELLENDE WAARDE ...................................................................................................... 17
5.6 GEBRUIK VAN TESTEN ............................................................................................................ 17
5.7 MEERVOUDIG TESTEN ............................................................................................................ 18
HOOFDSTUK 7: OBSERVATIONEEL ANALYTISCH ONDERZOEK ............................................................ 20
7.1 DWARSDOORSNEDE- OF CROSSSECTIONEEL ONDERZOEK ................................................................. 20
7.2 GEVALLENCONTROLE OF CASE-CONTROL ONDERZOEK ..................................................................... 20
7.3 COHORTONDERZOEK OF FOLLOW-UP ONDERZOEK ......................................................................... 20
HOOFDSTUK 8: EXPERIMENTEEL ANALYTISCH ONDERZOEK .............................................................. 22
8.1 LABO-EXPERIMENTEN ............................................................................................................ 22
1
, 8.2 KLINISCHE VELDSTUDIES ......................................................................................................... 22
HOOFDSTUK 9: RISICOMATEN ................................................................................................. 24
9.1 MAATSTAVEN VOOR ASSOCIATIE .............................................................................................. 24
9.1.1 RELATIEF RISICO ...................................................................................................................................... 24
9.1.2 PREVALENTIERATIO .................................................................................................................................. 24
9.1.3 ODDS RATIO ........................................................................................................................................... 24
9.2 MAATSTAVEN VOOR EFFECT .................................................................................................... 24
9.2.1 TOEWIJSBARE PROPORTIE VOOR DE BLOOTGESTELDEN .................................................................................... 24
9.2.2 TOEWIJSBARE PROPORTIE VOOR DE POPULATIE .............................................................................................. 25
HOOFDSTUK 10: PRECISIE EN ACCURAATHEID ............................................................................. 26
10.1 PRECISIE ........................................................................................................................... 26
10.2 ACCURAATHEID, JUISTHEID OF VALIDITEIT ................................................................................. 26
HOOFDSTUK 11: CAUSALITEIT................................................................................................. 28
11.1 CRITERIA VOOR CAUSALITEIT .................................................................................................. 28
HOOFDSTUK 12: EVIDENCE BASED VETERINARY MEDICINE ............................................................. 29
12.1 WETENSCHAPPELIJKE LITERATUUR ........................................................................................... 29
12.2 KWALITEIT VAN INFORMATIE ................................................................................................. 29
12.3 SYSTEMATISCHE REVIEW EN META-ANALYSE .............................................................................. 29
12.4 PUBLICATIE BIAS ................................................................................................................. 30
H13: RISICOANALYSE EN DIERZIEKTEBESTRIJDING ......................................................................... 31
13.1 RISICOANALYSE .................................................................................................................. 31
13.2 UITBRAAKONDERZOEK ......................................................................................................... 32
13.3 DIERZIEKTEBESTRIJDING ........................................................................................................ 32
AFRIKAANSE VARKENSPEST ................................................................................................................................ 32
RINDERPEST .................................................................................................................................................... 33
AVIAIRE INFLUENZA .......................................................................................................................................... 33
LUMPY SKIN DISEASE ........................................................................................................................................ 34
KLASSIEKE VARKENSPEST ................................................................................................................................... 34
MOND EN KLAUWZEER ...................................................................................................................................... 34
SARS-COV-2 ................................................................................................................................................. 34
ONE HEALTH ...................................................................................................................... 35
ANTIBIOTICUMRESISTENTIE ........................................................................................................... 35
GASTSPREKERS ................................................................................................................... 38
HADEWYCH VAN HAUWERMEIREN ................................................................................................. 38
VALERIE DE CLERCK..................................................................................................................... 38
ELKE ABBELOOS ......................................................................................................................... 38
LAETITIA CICCHELERO .................................................................................................................. 39
NELE CAEKEBEKE........................................................................................................................ 41
ECONOMIE VAN DE DIERGEZONDHEIDSZORG ............................................................................... 42
DE ROL VAN DIEREN IN DE MAATSCHAPPIJ ........................................................................................ 42
2
, WAT IS ECONOMIE?.................................................................................................................... 43
HOE ECONOMISCH BELANGRIJK IS ZIEKTE EN WAAROM? ....................................................................... 45
DIERGEZONDHEIDSZORG .................................................................................................................................... 45
ECONOMISCH EFFECT VAN ZIEKTE ........................................................................................................................ 46
EFFECT VAN ZIEKTE OP PRODUCTIVITEIT ................................................................................................................ 46
EFFECT VAN ZIEKTE OP WELZIJN ........................................................................................................................... 46
DE WAARDE VAN DE VOORNAAMSTE PRODUCTEN EN GRONDSTOFFEN IN DE VEEHOUDERIJ ........................... 47
MELK............................................................................................................................................................. 47
RUNDVLEES..................................................................................................................................................... 47
VARKENSVLEES ................................................................................................................................................ 47
KIPPENVLEES ................................................................................................................................................... 48
EIEREN ........................................................................................................................................................... 48
GRONDSTOFFEN (KOSTEN) ................................................................................................................................. 48
TOEKOMSTPERSPECTIEVEN VOOR VEEHOUDERIJ...................................................................................................... 49
HET BEREKENEN VAN DE ECONOMISCHE GEVOLGEN VAN ZIEKTE ............................................................. 50
VERLIEZEN DOOR ZIEKTE .................................................................................................................................... 50
BEREKENEN VAN ECONOMISCHE GEVOLGEN ........................................................................................................... 51
TECHNIEKEN VOOR BEREKENEN VAN ECONOMISCHE GEVOLGEN ................................................................................. 51
IMPACT BESLISSINGSNEMER................................................................................................................................ 52
NOODZAKELIJKE DATA ....................................................................................................................................... 52
ECONOMIE EN DIERENWELZIJN ............................................................................................................................ 52
ECONOMIE EN ZIEKTE BIJ DE MENS ....................................................................................................................... 53
DE ECONOMISCHE IMPACT VAN ENDEMISCHE ZIEKTEN EN VRUCHTBAARHEIDSSTOORNISSEN .......................... 53
OVERZICHT VAN ECONOMISCH BELANGRIJKSTE ENDEMISCHE ZIEKTEN .......................................................................... 53
MASTITIS BIJ MELKVEE ...................................................................................................................................... 54
PARASITAIRE INFECTIES BIJ MELKVEE..................................................................................................................... 54
ECONOMISCHE IMPACT VRUCHTBAARHEIDSSTOORNISSEN ......................................................................................... 55
DIERGENEESKUNDIGE BEDRIJFSBEGELEIDING ..................................................................................... 55
DE ECONOMISCHE EN SOCIALE IMPACT VAN EPIDEMISCHE DIERZIEKTEN .................................................... 56
BESTRIJDEN VAN EPIDEMISCHE DIERZIEKTEN .......................................................................................................... 56
ECONOMISCHE CONSEQUENTIES VAN EPIDEMISCHE DIERZIEKTEN ............................................................................... 56
3
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller stuviatralala. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $10.25. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
67096 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now